M O N T H L Y R E P O R T June 2005 Vol. 10, No. 6 Ajaib Singh, D.V.M.,Ph. D.

Similar documents
M O N T H L Y R E P O R T

M O N T H L Y R E P O R T January 2005 Vol. 10, No. 1 Ajaib Singh, D.V.M., Ph. D.

WSLH Testing and Surveillance Updates

UNION COUNTY 2017 COMMUNICABLE DISEASE REPORT

Collection (Specimen Source Required on all tests) Sputum: >5 ml required. First morning specimen preferred.

NON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS ISOLATED FROM BIRMINGHAM HEARTLANDS HOSPITAL: A CASE NOTES REVIEW.

What's the problem? - click where appropriate.

Infection Control Manual Residential Care Part 3 Infection Control Standards IC6: Additional Precautions

Rapid and progressive necrosis of the tissue underlying epidermis (cellulitis)

AMPLIRUN TOTAL A RELIABLE QUALITY CONTROL SOURCE FOR NUCLEIC ACID TESTS

Cleaning for Additional Precautions Table symptom based

Annual Epidemiological Report

WHEN IS CHILD MOST CONTAGIOUS? Variable, often from the day before symptoms begin up to 5 days after onset

Disease Transmission( Spread) Symptoms Infectious Period/ Exclusion. Should see physician as antibiotic treatment may be required

SPECIFIC DISEASE EXCLUSION GUIDELINES FOR CHILDCARE

M O L E C U L A R G E N E T I C S

WYANDOT COUNTY 2016 COMMUNICABLE DISEASE REPORT

WYANDOT COUNTY 2018 COMMUNICABLE DISEASE REPORT. The communicable disease summary of reportable infectious diseases for January 2018 December 2018.

Students. Exhibit - Reporting and Exclusion Requirements for Common Communicable Disease. Reporting Mandated to Local Health Authority

Communicable Disease Guidelines

WHAT DO U KNOW ABOUT STIS?

Bacterial Enteropathogens Faecal PCR and Culture Results

Communicable Disease Guidelines

OCCUPATIONAL HEALTH DISEASE SPECIFIC RECOMMENDATIONS

SELECTED INFECTIOUS DISEASES OF CHILDREN

Microbiology EQA Product Portfolio

DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations

Exclusion Periods for Infectious Diseases

Some medical conditions require exclusion from school or child care to prevent the spread of infectious diseases among staff and children.

5/1/2017. Sexually Transmitted Diseases Burning Questions

Timby/Smith: Introductory Medical-Surgical Nursing, 9/e

Welcome to Pathogen Group 6

ICM VI-09 DEFINITION REFERENCES

How is it transferred?

Specimen Type. Usual Tests Ordered

Chapter 11. Sexually Transmitted Diseases

CHAPTER 4: DISEASES SPREAD BY FOOD AND WATER

Chapter 17. Infectious Diseases

STIs- REVISION. Prof A A Hoosen

SPECIFIC DISEASE EXCLUSION FOR SCHOOLS

Dilemmas in the Management of Meningitis & Encephalitis HEADACHE AND FEVER. What is the best initial approach for fever, headache, meningisums?

Kent Count Health Department C O M M U N I C A B L E D I S E A S E S U M M A R Y

Microbiology Specimen Collection Instructions. Table I Culture and Sensitivities/TB

Mycobacterial Infections in HIV. H. Gene Stringer, Jr., MD Infectious Diseases Section Department of Medicine Morehouse School of Medicine

"Wanted Poster" Diseases

WYANDOT COUNTY 2016 COMMUNICABLE DISEASE REPORT

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND

2012 California Clinical Laboratory Survey: STD/HIV/Hepatitis Testing

INVASIVE MENINGOCOCCAL DISEASE (IMD), OTHER BACTERIAL MENINGITIS, HAEMOPHILUS INFLUENZAE & VIRAL MENINGITIS INFECTIONS IN IRELAND

Foodborne Disease in the Region of Peel

Foreword. Health protection service bulletin December HIV and sexually transmitted infections (STIs) in Northern Ireland.

Orientation Program for Infection Control Professionals

Patient: Ima Sample. Accession: Shiloh Rd, Ste 101. Collected: 9/4/2018. Received: 9/6/2018 Alpharetta GA

Quick Study: Sexually Transmitted Infections

INFECTIOUS DISEASE. Page 2

Patient: Ima Sample. Accession: Shiloh Rd, Ste 101. Collected: 2/10/2018. Received: 2/12/2018 Alpharetta GA

Nontuberculous Mycobacteria (NTM)

12/12/2011. Atypical Pneumonia. Objectives. Causative Agents of Acute Pneumonia Bacteria. Causative Agents of Acute Pneumonia Other Agents

Mycobacteriology William H. Benjamin, Jr.

Sexually Transmitted Infections

Telethon Speech and Hearing (TSH) Health Policy

Test Requested Specimen Ordering Recommendations

COMPREHENSIVE STOOL ANALYSIS

PATHOGEN DETECTION WITH THE FILMARRAY

New diagnostic tests for sexually transmitted infections. Jens Van Praet 30/11/2018

33. I will recommend this primer to my colleagues. A. Strongly Agree D. Disagree B. Agree E. Strongly Disagree C. Neither agree nor disagree

6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?

SEXUALLY TRANSMITTED DISEASES

Attendees will understand the early experience and clinical impact of GI multiplex PCR diagnostics in children

AHS Laboratory Services Central Zone Guide to Lab Services Manual Cultures/Procedures

In Canada and around the world, the trend is clear: sexually transmitted infections (STIs) are on the rise.

Rev. 6/18/2018. Specimen Type. Usual Tests Ordered

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND

TRAINER: Read this page ahead of time to prepare for teaching the module.

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB

HPSC - Weekly Infectious Disease Report

Treatment of febrile neutropenia in patients with neoplasia

Mechanisms of Pathogenicity

(3) Had a past illness from an infectious agent specified under paragraph (A)(1) of this rule; or:

Sexually Transmitted Infections (STIs)

Biology 3201 Unit 2 Reproduction: Sexually Transmitted Infections (STD s/sti s)

Pathogen specific exclusion criteria for people at increased risk of transmitting an infection to others

Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH

Infection Data: Form Updates

Potential Reimbursement CPT Codes

SOP Objective To prevent Healthcare Workers (HCWs) being a possible source of cross-infection to either patients or colleagues.

enter the room. Persons immune from previous varicella infection may enter the room without a mask. Those immune by adenoviruses, influenza viruses.

THE KENYA POLYTECHNIC UNIVERSITY COLLEGE

COLLECTION GUIDELINE FOR LABORATORY DIAGNOSIS OF COMMON VIRAL INFECTIONS

Nothing to disclose.

MYCOBACTERIOLOGY SERVICE MANUAL

Rapid-VIDITEST Enterovirus

Sexually Transmitted. Diseases

AFB Identification Texas Approach

Outline. Cryptococcosis Pneumocystosis Diarrhea. Case Histories: HIV Related- Opportunistic Infections in 2015

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Ministry of Social Affairs and Health, Finland N.B. Unofficial translation. Legally valid only in Finnish and Swedish

54 MMWR March 17, Appendix B. Guidelines for Confirmation of Foodborne-Disease Outbreaks

LTASEX.INFO STI SUMMARY SHEETS FOR EDUCATIONAL USE ONLY. COMMERCIAL USE RIGHTS RESERVED. COPYRIGHT 2013, JEROME STUART NICHOLS

Transcription:

ICROBIOLOGY DIVISION ILWAUKEE HEALTH DEPARTENT O N T H L Y R E P O R T June 2005 Vol. 10, No. 6 Ajaib Singh, D.V..,Ph. D. ICROBIOLOGY REPORT: The June 2005 issue of icrobiology onthly Report, Volume 10, presents the laboratory diagnosis of some of the infectious diseases, the reference microbiology work done in this laboratory during ay 2005 and new cases of syphilis in ilwaukee during April 2005. Information on the laboratory diagnosed mycobacterial infections in Wisconsin during April is also included. Legionnaires Disease (ay 2005) No positive case detected. Pertussis (Whooping cough,(ay 2005) No positive case detected.. Syphilis (ay 2005) Test Number Positive Test Number Positive RPR 1 TA-ABS 17 VDRL 34 DARKIELD 0 New Cases (Syphilis) The Wisconsin Division of Health has reported 4 new cases (early stages) of syphilis during April 2005 in ilwaukee. The median age of early syphilis cases is 31 years (range: 24-43 years). orbidity distributions of the disease reported in this and the corresponding month of the previous year are as follows:: New Cases of Syphilis (April 2005 and April 2004) Stage Number of Cases April 2005 April 2004 Primary syphilis 0 0 Secondary syphilis 0 2 Early latent syphilis 4 6 Late latent syphilis 0 2 Total 4 10 Gonorrhea ( HD ay 2005) Number Decreased Susceptibility (DS)/Resistance (R) to Antibiotics Tested Ciprofloxacin Ceftriaxone Spectinomycin Azithromycin 45 0 2 (DS) 0 0 Gonorrhea from Other Sources (ay 2005) Number Decreased Susceptibility (DS)/Resistance (R) to Antiobiotics Tested Ciprofloxacin Ceftriaxone Spectinomycin Azithromycin 5 0 0 0 0

Isolates Other Than N. gonorrhoeae (ay 2005) Organism Site Number Isolates Organism Ureaplasma urealyticum Site Number Isolates Genital 28 ycoplasma hominis Genital 8 Parasitic Enteric Pathogens (ay 2005) Age Sex Pathogen Number Cases 5 Giardia lamblia Blastocystis hominis 1 22 Entamoeba coli 1 23 Hymenolepis nana 1 ycobacterial Infections (ay 2005) No positive case detected. Reference Cultures (ay 2005) Age Sex Site/Specimen Source Culture Identification 59 Stool Campylobacter coli 79 N.A. Pasteurella multocida 59 Peritoneal Pasteurella gallinarum 90 Blood Aerococcus viridans 57 Blood Bacillus sp. (NOT B. anthracis) 7 Stool Escherichia coli O157:H7 59 Urine Proteus mirabilis 40 Stool Aeromonas sp 84 Blood Pasteurella gallinarum 80 Wound Oligella urethralis 80 Rt. inner calf Oligella urethralis 22 Stool Yersinia kristensenii 72 Stool Escherichia coli O157:H7 Bacterial Enteric Pathogens (ay 2005) Age Sex Pathogen Age Sex Pathogen 15 Shigella flexneri 87 Salmonella subsp II 50(Z):b:Z6 31 Shigella sonnei 27 Salmonella saintpaul 4 Shigella sonnei 32 Salmonella montevideo 4 Shigella sonnei 80 Salmonella enteritidis 4 Shigella sonnei 45 Salmonella enteritidis 16 Salmonella enteritidis 7mo Salmonella durham 84 Salmonella enteritidis 14 Salmonella kintambo 15 Salmonella enteritidis 64 Salmonella anatum 27 Salmonella enteritidis 23 Salmonella reading

Laboratory Diagnosed ycobacterial Infections in Wisconsin during April 2005 ycobacterium species Brown Dane Eau Claire Kenosha La Crosse ilwaukee Outagamie Racine Waukesha Winnebago Wood. tuberculosis complex Pul m 1 1 2 1 4 5 Total. tuberculosis complex 1 4 1 1 7. avium complex. gordonae. abscessus. chelonae. fortuitum group. kansasii. marinum. mucogenicum. xenopi. scrofulaceum Pulm 1 4 1 44 5 1 56 1 4 5 Pulm 2 8 4 17 1 2 34 1 1 Pulm 1 3 1 1 6 1 1 2 Pulm 1 1 Pulm 1 1 Pulm 1 1 2 Pulm Pulm 1 2 3 Pulm 5 5 Pulm 1 1 2. bovis BCG 1 1 TOTALS 4 14 2 4 1 80 0 2 1 8 3 119

-Pulmonary Sources of Isolation:. tuberculosis -pulmonary: 3 lymph node, 1 neck mass, 1 retro-peritoneal. avium complex pulmonary: 2 blood, 1 finger, 1 lung lesion, 1 paracentesis. gordonae -pulmonary: 1 nasal Other ycobacterium species 1 bovis BCG urine, 1 abscessus buttock, 1 abscessus elbow Wisconsin TB Isolations and Antibiotic Susceptibilities: 6 of the TBC isolates reported by Wisconsin laboratories this month were from Wisconsin TB cases. 1 case was from out-of-state. 4 of the TB isolates were susceptible to all first-line drugs tested. 1 isolate was resistant to INH (0.2 ug/ml and 1.0 ug/ml), rifampin and ethambutol. The isolate was susceptible to PZA. 1 isolate was susceptible to INH, rifampin, and ethambutol and resistant to PZA. 1 isolate was not tested (out-of-state). Source: ycobacteriology Laboratory Network Data Report, Wisconsin State Laboratory of Hygiene, adison, WI.

SUARY O CONIRED VIRUS INECTIONS ISSUE #1195 PAGE ONE ILWAUKEE HEALTH DEPARTENT VIROLOGY DIVISION, G. SEDAK, Ph.D. (414)286-3526 WEBSITE: www.milwaukee.gov/healthlab "We welcome any question or comments you have. Please see our "eedback" form on our website. VIRUS ISOLATION: WEEKS O JUNE 9 TO JULY 13, 2005 Patient Symptoms Specimen Submitted Virus 23 yr Aseptic meningitis CS 07/10/05 Coxsackievirus B5 13 mo No Information BAL/RK Cells 06/22/05 Coxsackievirus B5 6 wk eningitis NP/RK Cells 06/15/05 Coxsackievirus B5 25 mo Diarrhea Stool/RC-5 Cells 06/07/05 Coxsackievirus A20 NOTE: Enterovirus Cases 2005 to date: 1 x coxa20, 4 x coxb5 Total Cases = 5 As part of our enterovirus surveillance program, we test local sewage treatment plant influent (raw sewage) each month for culturable viruses. Over the past three months, the titer [PN(I.U.)/Liter] of Coxsackievirus B5 has increased each month: 10 PN/L in April, 42 PN/L in ay and 195 PN/L in June. Echovirus 9 and Coxsackievirus A4 were also detected in sewage collected in ay 2005. No information NP/RC-5 06/14/05 Rhinovirus 15 mo Cells 83 yr Leg lesion Lesion 06/13/05 Varicella-Zoster Virus 25 yr Penis lesion Lesion 07/11/05 HSV (Type 2 R-cheek lesion Lesion 07/11/05 HSV (Type 1

26 mo Vulva Lesion 07/08/05 HSV (Type 2 Cervical Lesion 07/08/05 HSV (Type 2 51 yr Penis Lesion 07/08/05 HSV (Type 2 25 yr Penis Lesion 07/01/05 HSV (Type 1 39 yr Penis Lesion 06/30/05 HSV (Type 2 28 yr Skin lesion Lesion 06/30/05 HSV (Type 2 SUARY O CONIRED VIRUS INECTIONS ISSUE #1195 PAGE TWO ILWAUKEE HEALTH DEPARTENT VIROLOGY DIVISION, G. SEDAK, Ph.D. (414)286-3526 VIRUS ISOLATION: WEEKS O JUNE 9 TO JULY 13, 2005 Patient Symptoms Specimen Submitted Virus 20 yr 41 yr 37 yr 28 yr 75 yr 18 yr 18 yr 32 yr Genital Lesion 06/29/05 HSV (Type 1 orehead Lesion 06/28/05 HSV (Type 1 lesion Penis Lesion 06/24/05 HSV (Type 2 Penis Lesion 06/23/05 HSV (Type 2 Oral lesions Throat 06/23/05 HSV (Type 1 Vaginal Lesion 06/22/05 HSV (Type 2 Cervical Lesion 06/21/05 HSV (Type 2 R-Groin Lesion 06/21/05 HSV (Type 2

22 yr 9 yr 20 yr 36 yr 32 yr 69 yr 25 yr 29 yr Lip sore Lower Lip Lesion 06/21/05 HSV (Type 1 Oral lesion NP 06/21/05 HSV (Type 1 Vulva Lesion 06/20/05 HSV (Type 1 Penis Lesion 06/16/05 HSV (Type 2 Penis Lesion 06/16/05 HSV (Type 2 Penis Lesion 06/15/05 HSV (Type 2 Buttock lesion Lesion 06/15/05 HSV (Type 2 Esophagitis Esophageal 06/13/05 HSV (Type 1 Brushing Penis Lesion 06/10/05 HSV (Type 1 Oral lesions outh Lesion 06/10/05 HSV (Type 1 SEROLOGY: Patient Symptoms Acute Serum Date Viral Agent 46 yr 22 yr 23 yr Clinic; HIV Screen 06/16/05 HIV+ by EIA Jail; HIV Screen 06/15/05 HIV+ by EIA Jail; HIV Screen 06/10/05 HIV+ by EIA Gerald V. Sedmak, Ph.D. Chief Virologist GVS/kb